Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Abeprazan is a potassium-competitive acid blocker (P-CAB).1,2 Abeprazan (20 µg/ml) increases trans-epithelial electrical resistance (TEER) and levels of the tight junction proteins occludin and mucin-1 (Muc-1) in a Caco-2 colon cell model of ulcerative colitis (UC) induced by dextran sulfate sodium (DSS; Item No. 23250).1 In vivo, abeprazan (20 mg/kg) reduces ileal levels of TNF-α, IL-6, and IL-1β in a mouse model of small intestinal injury induced by indomethacin (IDM; Item No. 70270).2 Formulations containing abeprazan have been used in the treatment of erosive esophagitis (EE) and gastroesophageal reflux disease (GERD).
WARNING This product is not for human or veterinary use.
1. Restoration of intestinal barrier function by fexuprazan, a potassium-
2. Fexuprazan mitigates NSAID-